P. J. Kuipers

发表

Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms

A. Bast, M. Drent, G. Koek, 2007, Alimentary pharmacology & therapeutics.

X‐chromosome inactivation patterns in females with Prader–Willi syndrome

D. J. Driscoll, Z. Talebizadeh, M. Theodoro, 2007, American journal of medical genetics. Part A.

1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities.

R. D. Dyer, D. Boschelli, R. Dyer, 1993, Journal of medicinal chemistry.

Hydroxylamine analogs of 2,6-di-t-butylphenols: dual inhibitors of cyclooxygenase and 5-lipoxygenase or selective 5-lipoxygenase inhibitors.

R. D. Dyer, R. Dyer, D. Bornemeier, 1995, Bioorganic & medicinal chemistry.

A versatile assay for gelatinases using succinylated gelatin.

H. Welgus, M. Mathrubutham, V. Baragi, 2000, Matrix biology : journal of the International Society for Matrix Biology.

Hypercholesterolemia causes mechanical weakening of rabbit atheroma : local collagen loss as a prerequisite of plaque rupture.

M. Rekhter, Jing Chen, W. Rosebury, 2000, Circulation research.

Selective regulation of human neutrophil functions by the cell activation inhibitor CI‐959

M. C. Conroy, C. Wright, M. Hoffman, 1994, Journal of leukocyte biology.

Unique and atypical deletions in Prader–Willi syndrome reveal distinct phenotypes

D. J. Driscoll, A. Beaudet, T. Sahoo, 2011, European Journal of Human Genetics.

Stimulus-dependent effects of CI-986 on arachidonic acid metabolism by human neutrophils

C. Wright, J. A. Kennedy, M. Ferin, 1995, Inflammation Research.

Inhibition of Human Neutrophil Activation by the Allergic Mediator Release Inhibitor, CI‐949

M. C. Conroy, C. Wright, M. Hoffman, 1991, Journal of leukocyte biology.

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.

C. Wright, R. Weishaar, L. Devall, 1990, Biochemical pharmacology.

Synthesis of reversed hydroxamic acids of indomethacin: dual inhibitors of cyclooxygenase and 5-lipoxygenase

R. D. Dyer, D. Boschelli, R. Dyer, 1992 .